Terms: = Skin cancer AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM AND Treatment
76 results:
1. Melanoma of the gallbladder.
Bojar P; Burdan F; Wronecki L; Szumiło J
Folia Med Cracov; 2023 Jul; 63(2):77-92. PubMed ID: 37903381
[TBL] [Abstract] [Full Text] [Related]
2. Should we abandon hormonal therapy in endometrial cancer? Outcomes of recurrent and metastatic endometrial cancer treated with systemic progestins.
Kulkarni A; Wright NMA; Forget AN; Ramsay T; Mallick R; Weberpals JI
Cancer Med; 2023 Aug; 12(15):16173-16180. PubMed ID: 37417528
[TBL] [Abstract] [Full Text] [Related]
3. Effect of Mind-Body Skills Training on Quality of Life for Geographically Diverse Adults With Neurofibromatosis: A Fully Remote Randomized Clinical Trial.
Vranceanu AM; Manglani HR; Choukas NR; Kanaya MR; Lester E; Zale EL; Plotkin SR; Jordan J; Macklin E; Bakhshaie J
JAMA Netw Open; 2023 Jun; 6(6):e2320599. PubMed ID: 37378983
[TBL] [Abstract] [Full Text] [Related]
4. Risk factors for seroma formation after axillary lymph node dissection with special focus on the impact of early shoulder exercise.
Borg G; Dihge L; Johansson K
Acta Oncol; 2023 May; 62(5):444-450. PubMed ID: 37129993
[TBL] [Abstract] [Full Text] [Related]
5. Effect of Phlorotannins from Brown Algae
Bakunina I; Imbs T; Likhatskaya G; Grigorchuk V; Zueva A; Malyarenko O; Ermakova S
Mar Drugs; 2022 Dec; 21(1):. PubMed ID: 36662206
[TBL] [Abstract] [Full Text] [Related]
6. Post-treatment Neck Dissection of Tonsillar and Base of Tongue Squamous Cell Carcinoma in the Era of PET-CT, HPV, and p16.
Landin D; Näsman A; Jara SJ; Hammarstedt-Nordenvall L; Munck-Wikland E; Dalianis T; Marklund L
Viruses; 2022 Jul; 14(8):. PubMed ID: 36016315
[TBL] [Abstract] [Full Text] [Related]
7. Biweekly administration of cetuximab in Japanese patients with recurrent or metastatic head and neck cancer.
Tanaka N; Enokida T; Fujisawa T; Okano S; Wada A; Sato M; Tanaka H; Takeshita N; Tahara M
Int J Clin Oncol; 2022 Nov; 27(11):1669-1674. PubMed ID: 35943644
[TBL] [Abstract] [Full Text] [Related]
8. Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada.
Marfil-Garza BA; Imes S; Verhoeff K; Hefler J; Lam A; Dajani K; Anderson B; O'Gorman D; Kin T; Bigam D; Senior PA; Shapiro AMJ
Lancet Diabetes Endocrinol; 2022 Jul; 10(7):519-532. PubMed ID: 35588757
[TBL] [Abstract] [Full Text] [Related]
9. Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial.
Gershenson DM; Miller A; Brady WE; Paul J; Carty K; Rodgers W; Millan D; Coleman RL; Moore KN; Banerjee S; Connolly K; Secord AA; O'Malley DM; Dorigo O; Gaillard S; Gabra H; Slomovitz B; Hanjani P; Farley J; Churchman M; Ewing A; Hollis RL; Herrington CS; Huang HQ; Wenzel L; Gourley C
Lancet; 2022 Feb; 399(10324):541-553. PubMed ID: 35123694
[TBL] [Abstract] [Full Text] [Related]
10. Pleomorphic dermal sarcoma: Clinicopathological features and outcomes from a 5-year tertiary referral centre experience.
Logan IT; Vroobel KM; le Grange F; Perrett CM
Cancer Rep (Hoboken); 2022 Nov; 5(11):e1583. PubMed ID: 34766474
[TBL] [Abstract] [Full Text] [Related]
11. Stereotactic body radiotherapy for head and neck skin cancer.
Voruganti IS; Poon I; Husain ZA; Bayley A; Barnes EA; Zhang L; Chin L; Erler D; Higgins K; Enepekides D; Eskander A; Karam I
Radiother Oncol; 2021 Dec; 165():1-7. PubMed ID: 34648871
[TBL] [Abstract] [Full Text] [Related]
12. Combination of radiotherapy and targeted therapy for melanoma brain metastases: a systematic review.
Ge Y; Che X; Gao X; Zhao S; Su J
Melanoma Res; 2021 Oct; 31(5):413-420. PubMed ID: 34406985
[TBL] [Abstract] [Full Text] [Related]
13. Combining Nd:YAG laser with optical coherence tomography for nonsurgical treatment of basal cell carcinoma.
Markowitz O; Bressler MY
Lasers Surg Med; 2022 Jan; 54(1):105-112. PubMed ID: 34289512
[TBL] [Abstract] [Full Text] [Related]
14. Health Care Utilization and Costs Associated With Systemic First-Line Metastatic Melanoma Therapies in the United States.
van Boemmel-Wegmann S; Brown JD; Diaby V; Huo J; Silver N; Park H
JCO Oncol Pract; 2022 Jan; 18(1):e163-e174. PubMed ID: 34228489
[TBL] [Abstract] [Full Text] [Related]
15. Transcriptomic landscape of circulating mononuclear phagocytes in Langerhans cell histiocytosis at the single-cell level.
Shi H; He H; Cui L; Kvedaraite E; Bian Z; Huang T; Lee CZW; Li Z; He J; Gong Y; Li Z; Zhou J; Zeng Y; Li X; Ni Y; Bai Z; Liu C; Li N; Ma H; Wang D; Lan Y; Ginhoux F; Zhang R; Liu B
Blood; 2021 Oct; 138(14):1237-1248. PubMed ID: 34132762
[TBL] [Abstract] [Full Text] [Related]
16. Effectiveness and Tolerability of First-Line Afatinib for Advanced EGFR-Mutant Non-Small Cell Lung cancer in Vietnam.
Vu TH; Nguyen HTT; Dao LK; Duong CK; Nguyen CV; Doan TT; Nguyen HTT; Hoang HH; Dinh DK; Le GV; Vu TT; Truong MC; Nguyen LT
Asian Pac J Cancer Prev; 2021 May; 22(5):1581-1590. PubMed ID: 34048189
[TBL] [Abstract] [Full Text] [Related]
17. Risk Factors for Relapse after Intentional Discontinuation of Immune Checkpoint Inhibitors in Melanoma Patients.
Persa OD; Schatton K; Rübben A; Berking C; Erdmann M; Schlaak M; Mauch C; Steeb T
J Immunother; 2021 Jul-Aug 01; 44(6):239-241. PubMed ID: 34028389
[TBL] [Abstract] [Full Text] [Related]
18. Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy.
Ghisoni E; Wicky A; Bouchaab H; Imbimbo M; Delyon J; Gautron Moura B; Gérard CL; Latifyan S; Özdemir BC; Caikovski M; Pradervand S; Tavazzi E; Gatta R; Marandino L; Valabrega G; Aglietta M; Obeid M; Homicsko K; Mederos Alfonso NN; Zimmermann S; Coukos G; Peters S; Cuendet MA; Di Maio M; Michielin O
Eur J Cancer; 2021 May; 149():153-164. PubMed ID: 33865201
[TBL] [Abstract] [Full Text] [Related]
19. Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients.
Taugner J; Käsmann L; Eze C; Rühle A; Tufman A; Reinmuth N; Duell T; Belka C; Manapov F
Invest New Drugs; 2021 Aug; 39(4):1189-1196. PubMed ID: 33704621
[TBL] [Abstract] [Full Text] [Related]
20. Immune-related adverse events of a PD-L1 inhibitor plus chemotherapy versus a PD-L1 inhibitor alone in first-line treatment for advanced non-small cell lung cancer: A meta-analysis of randomized control trials.
Wang M; Liang H; Wang W; Zhao S; Cai X; Zhao Y; Li C; Cheng B; Xiong S; Li J; He J; Liang W
Cancer; 2021 Mar; 127(5):777-786. PubMed ID: 33119182
[TBL] [Abstract] [Full Text] [Related]
[Next]
